Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

VFC's Stock House: Synergy Pharmaceuticals (SGYP) Ready To Roll

(EMAILWIRE.COM, May 22, 2012 ) New York, NY -- VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, reported today that Synergy Pharmaceuticals (SGYP) may be in a position to realize significant share price gains over the coming months.

Synergy Pharmaceuticals (SGYP) ran to over seven dollars last month on increasing volume as the company's billion dollar potential took shape and numerous analysts jumped on board with encouraging write-ups and bold price predictions.

Synergy also received a boost when its chief competitor, Ironwood Pharmaceuticals (IRWD) received a setback at the FDA that allows SGYP an extra three months to play catch up in the race to commercialization for each company's respective product candidate, both of which target the same indication. Synergy's product Plecanatide, however, has a much more favorable side effect profile, making the Ironwood setback that much more of a key factor when discussing future market potential.

Both products, Synergy's Plecanatide and Ironwood's Linaclotide, are being developed to treat chronic idiopathic constipation (CIC) and constipation-predominant irritable bowel syndrome (IBS-C). Linaclotide is already before the FDA for review, although the review was delayed by three months, as mentioned before, while Phase II/III Plecanatide results are due out later this year.

The head start to market may provide Ironwood with a distinct advantage, but the advantage might not last too long when Plecanatide shows up on the scene.

During the Linaclotide trials, the drug was successful in alleviating symptoms relating to IBS-C and CIC when compared to a placebo, but the kicker is that patients experienced side effects that included cases of extreme diarrhea, essentially reversing the symptom being treated. Some cases of diarrhea were so bad that 6% of the patients decided to abandon the trial altogether.

On the open market - with a competing product out there for which there have been no such cases noted - that means those patients would likely switch to the alternative, in this case Plecanatide, that is not associated with carrying around a roll of Charmin' Soft at all times.

For full report visit:

For full report and opinion visit:

Follow VFC's Stock House on Twitter:!/VFCsStockHouse

'Like' VFC's Stock House on Facebook:


VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.

For full disclaimer visit:

VFC's Stock House


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.

Express Scripts sees $750 mln in spending on new cholesterol drugs
6 Oct 2015 at 2:32pm
Express Scripts Holding Co, the largest manager of prescription drug plans for U.S. employers and health plans, said it has reached deals to cover two costly new cholesterol drugs and expects to spend no more than $750 million on them next year. The injected drugs - Repatha from Amgen Inc and Praluent from partners Regeneron Pharmaceuticals Inc and Sanofi - each have list prices of more than $14,000 a year. Express Scripts, which has been a vocal critic of rising U.S. drug prices, would not comment on how much of a discount it had negotiated.

AmerisourceBergen to buy PharMEDium for $2.58 billion
6 Oct 2015 at 2:23pm
(Reuters) - Drug distributor AmerisourceBergen Corp agreed to buy PharMEDium Healthcare Holdings Inc for $2.58 billion from private equity firm Clayton, Dubilier & Rice, expanding its business of supplying compounded drugs to hospitals. Compounding is a process in which pharma products are diluted to create doses that are not sold commercially. Increased regulatory oversight following a fungal meningitis outbreak at a compounding pharmacy in 2012 has escalated the costs for hospitals to produce compounded products internally, boosting demand for large-scale firms such as PharMEDium. ...

Family Looks Back at Brittany Maynard???s Fight After California ???Death Wit...
6 Oct 2015 at 2:23pm
Brittany Maynard died last year after bringing attention to ???aid-in-dying??? legislation.

Ohio sues Toledo over marijuana decriminalization ordinance
6 Oct 2015 at 2:19pm
Ohio Attorney General Mike DeWine and the Lucas County prosecutor and sheriff filed the lawsuit in Lucas County Common Pleas court against the "Sensible Marijuana Ordinance" passed in last month's Toledo municipal election. The ordinance eliminated fine and jail penalties for marijuana-related offenses in Ohio's fourth-largest city, according to DeWine.

Michigan providing water filters in Flint after high lead readings
6 Oct 2015 at 2:12pm
By Serena Maria Daniels DETROIT (Reuters) - Michigan on Tuesday began distributing free water filters to residents of Flint, a week after confirming that some children had elevated levels of lead in their blood since the city began taking water from a nearby river. The state last week confirmed a recent study at Hurley Children's Hospital that found increased lead levels in blood tests for children living in two Flint ZIP codes. The city of about 100,000 residents started using the Flint River as its water source in 2014 after a state-appointed emergency manager ruled out a deal to keep buying water from Detroit, 66 miles (106 km) to the southeast.

FDA puts clinical hold on Advaxis cancer drug
6 Oct 2015 at 2:03pm
(Reuters) - Advaxis Inc said the U.S. Food and Drug Administration has put on hold the mid-stage trials of its experimental cancer drug after a patient died, sending its shares down 27 percent in extended trading. The clinical hold on the drug, axalimogene filolisbac, was issued after Advaxis submitted a safety report to the FDA, the company said on Tuesday. The company, however, said the patient died due to progression of cervical cancer and the drug played no role in her death.

Should doctors help infertility patients who cross borders for care?
6 Oct 2015 at 1:51pm
By Lisa Rapaport (Reuters Health) - Should doctors offer infertility treatment to patients who cross international borders to get care they can?t legally receive in their home country? Yes, if they want to, some ethicists argue in an essay in the European Journal of Obstetrics and Gynecology and Reproductive Biology. ?Physicians should abide by national laws,? lead author Wannes Van Hoof, a bioethicist at Ghent University in Belgium, said by email.

Benzene in traffic emissions tied to childhood leukemia
6 Oct 2015 at 1:38pm

By Kathryn Doyle (Reuters Health) - Traffic pollution near the home ? and specifically, benzene in the air - increases the risk of one type of childhood leukemia, according to a nationwide study in France. Leukemia, or cancer of the blood cells, is the most common cancer among children younger than age 15, according to the U.S. National Cancer Institute. Childhood leukemia is a very rare disease, so it is hard to have enough cases in one study to determine which risk factors play a role, but according to this and other large surveys, the evidence seems to be pointing toward an association between traffic emissions and childhood leukemia, said coauthor Denis Hemon of the Institute National de la Santé et de la Recherché Medical (INSERM) based in Paris.

Nevada agrees to pay San Francisco $400,000 over patient dumping
6 Oct 2015 at 12:20pm

Nevada has agreed to pay the city of San Francisco $400,000 to settle a lawsuit claiming that the state bused patients, many of them poor and mentally ill, from a Las Vegas hospital to the Bay Area without plans for their care, Governor Brian Sandoval's office said on Tuesday. The settlement, which must still be approved by the San Francisco Board of Supervisors and the Nevada Board of Examiners, includes attorneys' fees and a plan for better management and transfer of patients. "We look forward to working with California to ensure all patient transfers to and from both states are managed using these best practices and adhering to conditions detailed in the agreement," Sandoval's office said in a statement.

Mom Says Flight Attendant Shamed Her for Using Breast Pump in Plane Bathroom
6 Oct 2015 at 11:52am
Mom says flight attendant embarrassed her on flight for pumping breast milk in plane bathroom.

FDA's new anti-smoking campaign uses hip-hop to target youth
6 Oct 2015 at 11:48am

WASHINGTON (AP) ? Government health officials are betting they can adapt the sounds, style and swagger of hip-hop culture to discourage young African Americans, Hispanics and other minority youths from using tobacco.

More U.S. women may get IUDs right after giving birth
6 Oct 2015 at 11:17am

By Lisa Rapaport (Reuters Health) - For new mothers in the U.S. who receive government-sponsored health insurance, it?s becoming easier to get intrauterine devices (IUDs) implanted immediately after giving birth, a study found. ?Immediate insertion is associated with more women who want an IUD implant actually getting it, higher use at three months postpartum, and lower rates of unplanned rapid repeat pregnancies within 12 to 24 months of delivery,? said lead study author Dr. Michelle Moniz of the University of Michigan in Ann Arbor, in email to Reuters Health. ?Furthermore, multiple analyses suggest that this strategy is cost-effective.? Just three years ago, no state Medicaid programs paid for these contraceptive devices to be implanted right after delivery.

Four die as Singapore hospital suffers wave of hepatitis C infections
6 Oct 2015 at 10:58am

Singapore's largest hospital apologised Tuesday after 22 kidney patients were infected with hepatitis C, with four dying in a rare outbreak at the prestigious facility. The infections at the government-run Singapore General Hospital (SGH) involved patients admitted to one ward between April and June. Hospital officials said while the four fatalities had other serious conditions, they "are not able to rule out the possibility" that hepatitis C could have been a factor in their deaths.

Mass immigration damaging Britain, says May
6 Oct 2015 at 10:58am

By William James MANCHESTER, England (Reuters) - Mass immigration is damaging British society, Conservative interior minister Theresa May said on Tuesday, promising a tough approach on an issue that will influence Britons' choice of whether or not to leave the European Union. "When immigration is too high, when the pace of change is too fast, it's impossible to build a cohesive society," May, seen as a possible future leader, told a party conference in the northern city of Manchester. Mass immigration strained public services like schools and hospitals, depressed wages and pushed people out of work, she said, describing the economic benefits as "close to zero".

Rihanna says thought she could be Chris Brown's 'guardian angel'
6 Oct 2015 at 10:51am

Grammy-winning R&B singer Rihanna said she once felt she was strong enough to take back boyfriend Chris Brown after he famously assaulted her in 2009, but finally realized she had been stupid to think that way. Explaining why she took him back after he left her bloodied on the eve of the Grammy awards, Rihanna, 27, said she thought "Maybe I?m one of those people built to handle ... this. "Maybe I?m the person who's almost the guardian angel to this person, to be there when they?re not strong enough" and to be able to "say the right thing." But the singer, actress and designer who has become one of the best-selling musical acts of the past decade said she "finally had to say, ?Uh-oh, I was stupid thinking I was built for this.? Sometimes you just have to walk away." "I don't hate him," Rihanna said, adding "I will care about him until the day I die. is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.

GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | | i-Canada-News.Com | | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | | | | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | - Medicl Newswire and Press Release service of GroupWeb Media LLC